Amgen is planning to push its olpasiran candidate for reducing lipoprotein(a) into phase 3 as quickly as possible as it tries to catch up with rival programmes at Novartis.

Microsoft is excited to introduce two, first-of-their-kind reasoning agents in Microsoft 365 Copilot: Researcher and Analyst. Learn more.